These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 16968494

  • 1. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ, Hilbrands LB.
    Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
    [Abstract] [Full Text] [Related]

  • 2. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K, Webber SA, Kurland G, Boyle GJ, Miller SA, Cipriani L, Griffith BP, Fricker FJ.
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [Abstract] [Full Text] [Related]

  • 3. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC, Lam MF, Yip PS, Li FK, Lai KN, Chan TM.
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [Abstract] [Full Text] [Related]

  • 4. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation.
    Rodrigo E, Piñera C, de Cos MA, Sánchez B, Ruiz JC, Fernández-Fresnedo G, Palomar R, González-Cotorruelo J, Gómez-Alamillo C, de Castro SS, de Francisco AL, Arias M.
    Transpl Int; 2005 Oct; 18(10):1152-7. PubMed ID: 16162102
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T, CRAF Study Group.
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K, Kishikawa H, Kato T, Kobayashi Y, Fujii N, Takahara S, Ichikawa Y.
    Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
    [Abstract] [Full Text] [Related]

  • 7. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D, Keitel E, Heineck I, Cardoso BD, Rodrigues AP, Michel K, Garcia VD.
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
    Roland M, Gatault P, Doute C, Büchler M, Al-Najjar A, Barbet C, Chatelet V, Marlière JF, Nivet H, Lebranchu Y, Halimi JM.
    Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
    [Abstract] [Full Text] [Related]

  • 9. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience.
    Marin M, Renoult E, Bondor CI, Kessler M.
    Transplant Proc; 2005 May; 37(4):1851-6. PubMed ID: 15919484
    [Abstract] [Full Text] [Related]

  • 11. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 12. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
    Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) investigators.
    Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
    [Abstract] [Full Text] [Related]

  • 13. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 14. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [Abstract] [Full Text] [Related]

  • 15. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Li CS.
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F, Auyanet I, Torregrosa JV, Oppenheimer F.
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [Abstract] [Full Text] [Related]

  • 17. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
    Jardine AG.
    Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.
    Ollech JE, Kramer MR, Peled N, Ollech A, Amital A, Medalion B, Saute M, Shitrit D.
    Eur J Cardiothorac Surg; 2008 May; 33(5):844-8. PubMed ID: 18339554
    [Abstract] [Full Text] [Related]

  • 19. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
    Gelens MA, Christiaans MH, van Hooff JP.
    Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
    [Abstract] [Full Text] [Related]

  • 20. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A.
    Transplantation; 2003 Nov 15; 76(9):1320-6. PubMed ID: 14627910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.